Local view for "http://purl.org/linkedpolitics/eu/plenary/2003-12-16-Speech-2-083"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20031216.3.2-083"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
".
I support this proposal, and the work carried out by the rapporteur, Mr Pirker, and I congratulate the Council, which took account of most of the proposals tabled by the European Parliament at first reading.
This initiative is intended to turn Directive 92/109 into a regulation, so as to enable the legislation to be simplified, making it easier to apply in a uniform way and at the same time. This has become even more relevant with the enlargement of the Union, because otherwise, for every amendment tabled to this Directive or to its annexes, national implementing measures would have to be established in 25 Member States.
This is, therefore, an attempt to achieve the harmonised monitoring of the trade in drug precursors and to prevent their being diverted into the illicit manufacture of narcotic drugs. The intention is also to facilitate legitimate trade in precursors within the internal market, used for legal and legitimate purposes, such as the manufacture of medicines.
Given the growing increase in the production of and trade in synthetic drugs, effective and rigorous monitoring of the manufacture and marketing of these substances must be set up, as they can be diverted to the illicit manufacture of narcotic drugs and psychotropic substances. At the same time, there must be close cooperation between the competent authorities and the economic operators in the chemicals industry."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples